Diagnostics

Photo

Article • Digital Pathology

CAD in pathology

Computer-aided diagnosis could soon play a greater role in digital pathology. Dr Jeroen van der Laak, an Assistant Professor in Digital Pathology at Radboud University, believes a breakthrough that would increase the speed and accuracy of diagnoses and prognoses is closer than many observers think Report: Mark Nicholls

Photo

Sponsored • CardioSecur

New mobile ECG gives 360-degree view

The conventional 12-lead ECG has certainly proved its worth in displaying rhythm disorders or ischemia. Nevertheless, as the display possibilities of a 12-lead ECG are limited to only about 110 degrees of the heart, an exact location of a cardiac event often cannot be determined.

Photo

Article • Diagnostic toolkit

New cardiac genetic testing panels

As new cardiac genetic testing panels become available, cardiologists have been warned not to lose sight of the importance of comprehensive clinical evaluation. While genetic testing is helping to identify more people at risk of inherited conditions, experts stress they are only part of the diagnostic toolkit.

Photo

News • Diagnostic station DS20

Modern and practical design unites the most demanded functions

Schiller's Diagnostic Station DS20 simplifies the daily work: most vital signs and physical assessment tools united in one device; large, interactive touch screen; intuitive guidance and ease of use. Launch of the Diagnostic Station DS20 is going to take place at the ESC in London (29th August – 2nd September 2015).

Photo

News • AACC News

New tests to diagnose and monitor diabetes

Researchers have successfully tested two new potential methods for diagnosing and monitoring diabetes in its standard and gestational forms. These findings, presented at the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta, may lead to easier, timelier, and more affordable ways of identifying and treating this chronic disease.

Photo

News • Aspergillus

ESCMID cautions that Europe is now a hotbed of global fungal resistance

ESCMID Fungal Infection Study Group (EFISG) argues that fungal resistance now represents a huge healthcare threat – with many cases remaining massively undiagnosed even in the developed world – and that there is a rising prevalence of the most invasive and deadly forms. Conversely, in the developing world we are seeing very treatable fungal infections killing huge numbers – half a million…

Photo

News • AACC News

Rapid Ebola test could help end lingering outbreak

Research presented at the 2015 AACC Annual Meeting & Clinical Lab Expo will expand on the studies that led to a fingerprick Ebola test becoming the first and only rapid diagnostic for this disease to receive approval from the World Health Organization (WHO). This test could prove vital to breaking Ebola’s grip on West Africa by identifying suspected Ebola cases within minutes, and enabling…

Photo

Sponsored • Best Places to Work

A laboratory fit for a future decade

Fostering a collaborative way of working won the UK’s Dartford and Gravesham NHS Trust recognition as an elite public sector healthcare employer, recently judged one of the top 100 ‘Best Places to Work’. The trust, led by chief executive Susan Acott, has created an energy-driven, patient-focused culture within the hospital, reflected by staff at all levels. This has been the driving force…

Photo

Article • UTI pathogen

Boosting the Body’s Natural Ability to Fight Urinary Tract Infections

Urinary tract infections (UTIs) are common, and widespread antibiotic resistance has led to urgent calls for new ways to combat them. Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that an experimental drug that stabilizes a protein called HIF-1alpha protects human bladder cells and mice against a major UTI…

Photo

Article • Infection control

From alcohol to cancer detection

Clinical trials are under way at two NHS hospitals in England to assess breathalyser technology to detect lung cancer. Phase I clinical trials of a diagnostic breathalyser developed by Cambridge-based Owlstone Ltd have shown accurate identification of 12 lung cancer biomarkers in breath specimens. A Phase II trial is now targeting development of a small, handheld device that can be used in GP…

66 show more articles
Subscribe to Newsletter